Peroxisome proliferator-activated receptor α/γ dual Agonists for the treatment of type 2 diabetes

被引：130
|
作者：
Henke, BR [1 ]
机构：
[1] GlaxoSmithKline, Metab & Viral Dis Drug Discovery Res, Res Triangle Pk, NC 27709 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 17期
关键词：
D O I：
10.1021/jm030631e
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：4118 / 4127
页数：10
相关论文
共 50 条
  • [1] Design, synthesis and evaluation of peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes
    Das, Saibal Kumar
    Abbineni, Chandrasekhar
    Rao, Krovvidi Venkata Lakshmi Narasimha
    Iqbal, Javed
    Babu, Ravi Krishna
    Chakrabarti, Ranjan
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (01) : 27 - 32
  • [2] Discovery of a novel series of peroxisome proliferator-activated receptor α/γ dual agonists for the treatment of type 2 diabetes and dyslipidemia
    Liu, K
    Xu, LB
    Berger, JP
    MacNaul, KL
    Zhou, GC
    Doebber, TW
    Forrest, MJ
    Moller, DE
    Jones, AB
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (07) : 2262 - 2265
  • [3] Peroxisome proliferator-activated receptor (PPAR)γ agonists for diabetes
    Moller, DE
    Greene, DA
    ADVANCES IN PROTEIN CHEMISTRY, VOL 56: DRUG DISCOVERY AND DESIGN, 2001, 56 : 181 - +
  • [4] Peroxisome proliferator-activated receptor agonists
    Willson, TM
    Wahli, W
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (02) : 235 - 241
  • [5] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [6] Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists
    Olefsky, JM
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04): : 467 - 472
  • [7] Evolution of peroxisome proliferator-activated receptor agonists
    Chang, Feng
    Jaber, Linda A.
    Berlie, Helen D.
    O'Connell, Mary Beth
    ANNALS OF PHARMACOTHERAPY, 2007, 41 (06) : 973 - 983
  • [8] Kojyl cinnamate esters are peroxisome proliferator-activated receptor α/γ dual agonists
    Kim, Sae On
    Han, Yujia
    Ahn, Sungjin
    An, Seungchan
    Shin, Jeayoung C.
    Choi, Hyunjung
    Kim, Hyoung-June
    Park, Nok Hyun
    Kim, Yong-Jin
    Jin, Sun Hee
    Rho, Ho Sik
    Noh, Minsoo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (21) : 5654 - 5663
  • [9] Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes
    Blaschke, F
    Takata, Y
    Caglayan, E
    Law, RE
    Hsueh, WA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (01) : 28 - 40
  • [10] Selective peroxisome proliferator-activated receptorα modulators (SPPARMα): The next generation of peroxisome proliferator-activated receptor α-agonists
    Jean-Charles Fruchart
    Cardiovascular Diabetology, 12
12345